BIIB

BIIB

Biogen Inc
Biotechnology
$218.12 +0.62% As of Aug 25, 12:41 AM
Loading chart...
Interactive chart powered by TradingView

Trade Idea

Strategy
Live Scanner Strategy
Strikes
$220/215
Expiration
Sep 18
Target ROI
80.0%
Bullish Factors
High AI confidence rating, Moving averages show bullish trend
Risk Factors
Earnings announcement within 3 days

Technical Analysis

BIIB Coiled Spring Ready to Release at $218.12

Neutral
Aug 25, 2026 at 12:41 AM $218.12 (+0.62%)

Biogen Inc (BIIB) advanced 0.62%, ending the session at $218.12 on August 25.

Technical indicators paint a bullish picture:

Moving Averages Price trades above the 9-day EMA ($214.00) with a bullish stack. The 21-day EMA at $210.24 provides support.
Momentum RSI at 60.1 is in neutral territory. MACD reads 3.57 against its 2.59 signal line (bullish).
Volatility Stock has been in a TTM Squeeze for 20 days, indicating compressed volatility and potential for a significant move.

Support sits at $199.62 with resistance at $219.35.

Squeeze Play: BIIB Preps for Breakout at $218.12

Neutral
Aug 24, 2026 at 9:02 PM $218.12 (+0.62%)

BIIB Volatility Squeeze Intensifies at $216.78

Neutral
Aug 23, 2026 at 5:08 AM $216.78 (+1.14%)

BIIB Range Contracts Sharply Near $216.78

Neutral
Aug 22, 2026 at 3:00 AM $216.78 (+1.14%)

Calm Before Storm? BIIB Squeezes at $216.78

Neutral
Aug 21, 2026 at 9:01 PM $216.78 (+1.14%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month

Key Stats

Entry Price $5.70
Max Profit $-10.70
Max Loss $5.70
Days to Exp 23
Trade Date Aug 25, 2026
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.